Medicine Man Technologies Inc (MDCL) financial statements (2020 and earlier)

Company profile

Business Address 4880 HAVANA STREET
DENVER, CO 80239
State of Incorp. NV
Fiscal Year End December 31
SIC 8742 - Management Consulting Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments120100
Cash and cash equivalents120100
Receivables13100
Inventory, net of allowances, customer advances and progress billings100  
Inventory100  
Prepaid expense1   0
Other current assets1000 
Other undisclosed current assets   00
Total current assets:163210
Noncurrent Assets
Operating lease, right-of-use asset0
Nontrade receivables3    
Property, plant and equipment00000
Long-term investments and receivables0    
Accounts and financing receivable, after allowance for credit loss0    
Intangible assets, net (including goodwill)1212900
Goodwill12129  
Intangible assets, net (excluding goodwill)00000
Other noncurrent assets  0  
Other undisclosed noncurrent assets12   
Total noncurrent assets:17151000
TOTAL ASSETS:32181110
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities210 0
Accounts payable100 0
Accrued liabilities10   
Employee-related liabilities0    
Taxes payable 1  0
Derivative instruments and hedges, liabilities4  0 
Due to related parties000  
Other liabilities  00 
Total current liabilities:61000
Noncurrent Liabilities
Long-term debt and lease obligation0  1 
Long-term debt, excluding current maturities   1 
Operating lease, liability0
Other undisclosed noncurrent liabilities  0  
Total noncurrent liabilities:0 01 
Total liabilities:61010
Stockholders' equity
Stockholders' equity attributable to parent271711(0)0
Common stock00000
Treasury stock, value(1)    
Additional paid in capital50201410
Accumulated other comprehensive loss   (0)(0)
Retained earnings (accumulated deficit)(23)(6)(7)(1)0
Other additional capital 34  
Total stockholders' equity:271711(0)0
TOTAL LIABILITIES AND EQUITY:32181110

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues129411
Revenue, net411
Cost of revenue(8)(3)(1)(0)(0)
Cost of goods and services sold(8)(2)(1)(0)(0)
Gross profit:57201
Operating expenses(22)(5)(7)(1)(1)
Operating income (loss):(17)2(5)(1)0
Nonoperating income (expense)(0)(1)(0)(0)0
Other nonoperating income (expense)  (0)(0)0
Interest and debt expense  (0)(0) 
Income (loss) from continuing operations before income taxes:(18)2(5)(1)0
Income tax expense (benefit)1(1)  (0)
Net income (loss):(17)1(5)(1)0
Other undisclosed net income attributable to parent  00 
Net income (loss) available to common stockholders, diluted:(17)1(5)(1)0

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(17)1(5)(1)0
Comprehensive income (loss):(17)1(5)(1)0
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  00(0)
Comprehensive income (loss), net of tax, attributable to parent:(17)1(5)(1)0

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: